Trondheim, Norway

Kjell Morten Varum

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fmc Biopolymer as. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kjell Morten Varum. Retrieved from https://idiyas.com/inventor/kjell-morten-varum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kjell Morten Varum: Innovator in Oligonucleotide Delivery Systems

Introduction

Kjell Morten Varum is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of innovative delivery systems for oligonucleotides. His work focuses on enhancing the stability and efficacy of gene silencing techniques.

Latest Patents

Kjell Morten Varum holds a patent for "Oligonucleotide non-viral delivery systems." This patent describes how low molecular weight chitosan oligomers can self-assemble siRNA into nanosized particles. These particles provide protection against enzymatic degradation and facilitate stable gene silencing over extended periods in vitro. The control of structural variables in formulating complexes of siRNA with low molecular weight chitosans offers an efficient alternative delivery system for siRNA both in vitro and in vivo.

Career Highlights

Kjell Morten Varum is associated with Fmc Biopolymer AS, where he applies his expertise in biopolymer technology. His innovative approaches have the potential to revolutionize the delivery of genetic materials, making significant strides in therapeutic applications.

Collaborations

Some of his notable coworkers include Per Artur Sven Artursson and Mohamed Mahmoud Issa. Their collaborative efforts contribute to advancing research in the field of oligonucleotide delivery systems.

Conclusion

Kjell Morten Varum's work exemplifies the intersection of innovation and biotechnology. His contributions to oligonucleotide delivery systems are paving the way for future advancements in gene therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…